Europe
-
Blood enzyme may explain male virus susceptibility
The ACE2 enzyme may help explain why men are more vulnerable to the Covid-19 virus than women, Dutch researchers report today. Read more
-
Vaccine hope for type 1 diabetes viruses
A vaccine has been developed that could help to stop viruses that attack the autoimmune system and trigger type 1 diabetes, it was announced last night. Read more
-
Lowering androgen may protect against Covid-19
Androgen-deprivation therapy given for prostate cancer may be protective against Covid-19 for these patients, researchers say today. Read more
-
Antibody blocks infection of SARS-CoV-2 in cultured cells
Scientists have identified a fully human monoclonal antibody that prevents the SARS-CoV-2 virus from infecting cultured cells, it was announced last night. Read more
-
Men and women’s same three heart symptoms
The top three acute coronary symptoms are the same in both women and men, according to a new Dutch study published last night. Read more
-
Anti-Ebola drug and antibody show promise
The anti-Ebola drug remdesivir has shown major promise in a global clinical trial involved Covid-19 patients, it was announced last night. Read more
-
Preterm delivery risk following first pregnancy complications
Women who experience complications in their first pregnancy but deliver at full term are at increased risk of preterm delivery in their next pregnancy, according to a new Norwegian study. Read more
-
Hope for Covid-19 inflammation therapy
Scientists are working on a new nanoparticle treatment for septic shock and uncontrolled inflammation that might help Covid-19 care. Read more
-
Gut neurons linked to Parkinson’s disease
Researchers have investigated which types of nerve cells contain genes linked to Parkinson’s disease, pinpointing a cluster in the gut. Read more
-
Two nose cells likely Covid-19 entry points
Two specific cell types in the nose have been identified as likely initial infection points for Covid-19, according to a study published last night. Read more